Zacks Research Issues Optimistic Forecast for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Research analysts at Zacks Research increased their Q1 2027 EPS estimates for shares of Phibro Animal Health in a research note issued on Tuesday, January 7th. Zacks Research analyst R. Department now anticipates that the company will earn $0.49 per share for the quarter, up from their previous estimate of $0.47. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health's Q2 2027 earnings at $0.53 EPS.

Other equities research analysts have also recently issued reports about the company. StockNews.com raised Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, January 4th. Morgan Stanley lifted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Finally, Barclays increased their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $20.50.

Phibro Animal Health Trading Down 6.7 %

Phibro Animal Health stock traded down $1.43 during trading on Friday, hitting $20.05. The company had a trading volume of 128,810 shares, compared to its average volume of 170,735. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The company's 50 day simple moving average is $22.75 and its 200-day simple moving average is $21.08. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The stock has a market cap of $812.09 million, a price-to-earnings ratio of 46.63, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.39%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health's dividend payout ratio is currently 111.63%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Brandes Investment Partners LP raised its holdings in shares of Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company's stock valued at $40,521,000 after purchasing an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company's stock valued at $13,005,000 after buying an additional 42,086 shares in the last quarter. Dana Investment Advisors Inc. lifted its holdings in Phibro Animal Health by 17.2% during the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company's stock worth $8,619,000 after buying an additional 75,546 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Phibro Animal Health by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after acquiring an additional 27,201 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company's stock valued at $5,822,000 after acquiring an additional 189,068 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.